TrumpRx Reshapes Pharmaceutical Pricing as Pfizer Signs On
A new government-run drug purchasing website is set to change how Americans access prescription medications, and Pfizer became the first major pharmaceutical company to join the platform on Tuesday. The TrumpRx.gov agreement eliminates middlemen from the drug supply chain while establishing international price matching across developed countries. Pfizer stock responded with a 6.8% gain, though shares remain 13.3% below year-ago levels at the time of writing. Also Read: Saudi Arabia Buys EA Games in Kushner-Led $55B Takeover Pfizer (PFE) Stock Price Gains as TrumpRx Deal Cuts Drug Prices Source: KLLC Direct-to-Consumer Model Bypasses Traditional Distribution The rally came after the company agreed to match U.S. medication costs with those in other developed countries. Pfizer will also participate in TrumpRx.gov, which is fundamentally a government platform that will open in early 2026 and will remove pharmacy benefit managers out of the entire supply chain. The company will discount pri...